
Insights on Sacituzumab Govitecan for Triple-Negative Breast Cancer
Author(s) -
Dibash Kumar Das
Publication year - 2021
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000795976.27991.55
Subject(s) - medicine , breast cancer , triple negative breast cancer , oncology , metastatic breast cancer , clinical trial , chemotherapy , adjuvant , cancer